|
 |
Coffee may prevent colon cancer
Source: (cancerfacts.com)
Monday, October 13, 2003
WASHINGTON, D.C. – Oct. 13, 2003 - Drinking coffee may help prevent colon cancer, according to a group of researchers in Germany.
Although researchers have suspected for years that coffee consumption may offer some protection against cancer as a result of the drink's high anti-oxidant content, the German investigators say the finding represents the first time that a specific, highly active anti-cancer compound has been identified in the beverage.
Led by Dr. Thomas Hofmann, head of the Institute for Food Chemistry at the University of Munster in Germany, the study in laboratory cultures of human cells and in animals, identified a potent anti-oxidant compound in the popular brew that appears in to boost the activity of proteins, called phase II enzymes, which are thought to protect against colon cancer. The report is scheduled to appear in the Nov. 5 issue of the Journal of Agricultural and Food Chemistry, a peer-reviewed journal of the American Chemical Society.
"Until human studies are done, no one knows exactly how much coffee is needed to have a protective effect against colon cancer," Hofmann said in a prepared statement. "However, our studies suggest that drinking coffee may offer some protection, especially if it's strong. For example, espresso-type coffee contains about two to three times more of the anti-cancer compound than a medium roasted coffee beverage."
The anti-cancer compound, called methylpyridinium, is found almost exclusively in coffee and coffee products but is not found in significant amounts in other foods and beverages, Hofmann says. Its anti-cancer activity was unknown until now, he adds.
Methylpyridinium is not present in raw coffee beans but is formed during the roasting process from its chemical precursor, trigonellin, which is common in raw coffee beans. It is present in both caffeinated and decaffeinated coffee, and even in instant coffee, says Hofmann.
To investigate the theory that coffee fights cancer, Hofmann and Dr. Veronika Somoza and their associates prepared a conventional coffee beverage using roasted, decaffeinated beans from Columbia. Specially prepared extracts of the brew were then exposed to laboratory preparations of human intestinal cells for three days and results were compared to cells that were not exposed to coffee.
In the cell study, coffee extracts significantly boosted activity levels of phase II enzymes. The higher the quantity of coffee, the higher the activity level of the enzymes. Analysis of the extract showed that the most active anti-cancer compound was methylpyridinium.
To determine whether the compound had a similar effect in living systems, a group of 24 rats was evenly divided into three groups and each group was fed either a standard diet, a diet mixed with coffee extract, or a standard diet containing pure methylpyridinium.
Blood tests showed that rats fed the coffee extract had a 24 to 40 percent increase in phase II enzyme activity compared to control animals. Pure methylpyridinium also significantly boosted the enzymes' activity levels. The results provide strong support for coffee as a cancer fighter in living systems, Hofmann and Somoza say.
The researchers plan to conduct additional tests in the future to determine whether methylpyridinium is an effective cancer fighter in humans and whether it has any side effects.
Copyright © 2001, 2002, 2003 NexCura, Inc. All rights reserved. Republication or redistribution of cancerfacts.com content, including by framing or similar means, is expressly prohibited without the prior written consent of NexCura. NexCura® is a registered trademark and cancerfacts.com™ is a trademark of NexCura, Inc. or its affiliates. Copyright © 2001, 2002, 2003. All rights reserved. This information is for educational purposes only.
|
|
|
|
|
|
